Hospital groups join a multi-sector plea to the FTC to delay a new ban on noncompetes. A new study ties weight-loss drug Wegovy to reduced risk for alcohol use disorder. And drugmaker Eli Lilly says it will spend billions of dollars to expand its GLP-1 production capacity. That’s coming up on today’s episode of Gist Healthcare Daily.
","author_name":"Gist Healthcare Daily"}